Share

August 2021; 11 (4) Case

Antiglutamic Acid Decarboxylase 65 Antibody–Associated Hemiataxia

Emily J. Hill, Joseph Jankovic
First published August 26, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000939
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
110

Share

Article Information

vol. 11 no. 4 e564-e566
DOI: 
https://doi.org/10.1212/CPJ.0000000000000939
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received May 18, 2020
  • Accepted July 7, 2020
  • First Published August 26, 2020.

Article Versions

Copyright & Usage: 
© 2021 American Academy of Neurology

Author Disclosures

    1. Emily J. Hill, MD and
    2. Joseph Jankovic, MD
  1. Emily J. Hill, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Parkinson Study Group / Parkinson’s Foundation’s Mentored Clinical Research Award 2018-2020

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Joseph Jankovic, MD
    3. Scientific Advisory Boards:

    1. Prothena Biosciences Inc; Retrophin, Inc-Parexel; Teva Pharmaceutical Industries Ltd

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Teva Pharmaceutical Industries Ltd

    Editorial Boards:

    1. Acta Neurologica Scandinavica, Neurology Medlink, Neurotherapeutics, Expert Review of Neurotherapeutics, Journal of Parkinson’s Disease, Toxins

    Patents:

    1. NONE

    Publishing Royalties:

    1. Cambridge; Elsevier; Future Science Group; Hodder Arnold; Lippincott Williams and Wilkins; Wiley-Blackwell

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Allergan, Inc; Nuvelution; Retrophin, Inc-Parexel; Teva Pharmaceutical Industries Ltd;

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Allergan, Inc; CHDI Foundation; Civitas/Acorda Therapeutics; Dystonia Coalition; Dystonia Medical Research Foundation; F. Hoffmann-La Roche Ltd; Huntington Study Group; Medtronic Neuromodulation; Merz Pharmaceuticals; Michael J Fox Foundation for Parkinson Research; National Institutes of Health; Neurocrine Biosciences; Parkinson’s Foundation; Nuvelution; Parkinson Study Group; Pfizer Inc; Prothena Biosciences Inc; Psyadon Pharmaceuticals, Inc; Revance Therapeutics, Inc; Teva Pharmaceutical Industries Ltd; US WorldMeds.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Expert witness for defendant

  1. Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX.
  1. Correspondence
    Dr. Jankovic josephj{at}bcm.edu
View Full Text

Article usage

Article usage: August 2020 to January 2023

AbstractFullPdfSource
Aug 20209805Highwire
Sep 20205203Highwire
Oct 20203305Highwire
Nov 20205807Highwire
Dec 20204102Highwire
Jan 202179012Highwire
Feb 20214206Highwire
Mar 20213803Highwire
Apr 20212007Highwire
May 20211703Highwire
Jun 20213803Highwire
Jul 20211600Highwire
Aug 20214723716Highwire
Sep 202198125Highwire
Oct 202110722Highwire
Nov 20214132Highwire
Dec 20214200Highwire
Jan 20225355Highwire
Feb 20226931Highwire
Mar 20223100Highwire
Apr 20221411Highwire
May 20221801Highwire
Jun 20223311Highwire
Jul 20224808Highwire
Aug 20224704Highwire
Sep 20227202Highwire
Oct 20222101Highwire
Nov 20225714Highwire
Dec 20223501Highwire
Jan 20234900Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me